thymidine has been researched along with P carinii Pneumonia in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by Pneumocystis carinii pneumonia alone, or with advanced AIDS-related complex." | 9.06 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Schooley, RT; Volberding, PA, 1987) |
| "In a 6-week clinical trial 4 dose regimens of 3'-azido-3'-deoxythymidine (AZT), a thymidine analogue with potent anti-viral activity against HTLV-III in vitro, were examined in 19 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC)." | 5.06 | Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. ( Barry, DW; Blum, RM; Durack, DT; Gelmann, E; Klecker, RW; Lehrman, SN; Lyerly, HK; Markham, PD; Weinhold, KJ; Yarchoan, R, 1986) |
| "We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by Pneumocystis carinii pneumonia alone, or with advanced AIDS-related complex." | 5.06 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Schooley, RT; Volberding, PA, 1987) |
| "Patients with the acquired immunodeficiency syndrome (AIDS) die of overwhelming infections as a consequence of the destruction of the T4 subset of lymphocytes." | 2.37 | Developmental therapeutics and the acquired immunodeficiency syndrome. ( Broder, S; Chabner, BA; DeVita, VT; Fauci, AS; Kovacs, JA, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vestereng, VH | 1 |
| Kovacs, JA | 2 |
| DeVita, VT | 1 |
| Broder, S | 1 |
| Fauci, AS | 1 |
| Chabner, BA | 1 |
| Yarchoan, R | 1 |
| Klecker, RW | 1 |
| Weinhold, KJ | 1 |
| Markham, PD | 1 |
| Lyerly, HK | 1 |
| Durack, DT | 1 |
| Gelmann, E | 1 |
| Lehrman, SN | 1 |
| Blum, RM | 1 |
| Barry, DW | 1 |
| Blumenfeld, W | 1 |
| Basgoz, N | 1 |
| Owen, WF | 1 |
| Schmidt, DM | 1 |
| Azon-Masoliver, A | 1 |
| Mallolas, J | 1 |
| Gatell, J | 1 |
| Castel, T | 1 |
| Fischl, MA | 1 |
| Richman, DD | 1 |
| Grieco, MH | 1 |
| Gottlieb, MS | 1 |
| Volberding, PA | 1 |
| Laskin, OL | 1 |
| Leedom, JM | 1 |
| Groopman, JE | 1 |
| Mildvan, D | 1 |
| Schooley, RT | 1 |
| Furth, PA | 1 |
| Kazakis, AM | 1 |
| Flanigan, T | 1 |
| Shapiro, E | 1 |
| Graham, R | 1 |
| Goldblum, RM | 1 |
| Lord, RA | 1 |
| Dupree, E | 1 |
| Weinberg, AG | 1 |
| Goldman, AS | 1 |
| Bornstein, RS | 1 |
| Yarbro, JW | 1 |
1 review available for thymidine and P carinii Pneumonia
| Article | Year |
|---|---|
Developmental therapeutics and the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Deoxyribonucleosides; HIV; Humans; Interferons | 1987 |
2 trials available for thymidine and P carinii Pneumonia
| Article | Year |
|---|---|
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Body Weight; Clinical Trials as Topic; Del | 1986 |
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic | 1987 |
8 other studies available for thymidine and P carinii Pneumonia
| Article | Year |
|---|---|
Inability of Pneumocystis organisms to incorporate bromodeoxyuridine suggests the absence of a salvage pathway for thymidine.
Topics: Animals; Bromodeoxyuridine; Intestine, Small; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pneumocys | 2004 |
Treatment of pneumocystis pneumonia in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Humans; Pneumonia, Pneumocystis; Thymid | 1988 |
Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Antiviral Agents; Granuloma; Humans; Male; Pent | 1988 |
Zidovudine-induced nail pigmentation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Nail Diseases; Opportunistic Infections; Pi | 1988 |
Nail pigmentation changes associated with azidothymidine (zidovudine).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Black People; Female; Humans; Male; Nai | 1987 |
Prophylaxis against Pneumocystis carinii pneumonia in patients receiving azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Humans; Male; Middle Aged; Pneumonia, Pneumocysti | 1987 |
Transfer factor induced delayed hypersensitivity in X-linked combined immunodeficiency.
Topics: Bone Marrow Examination; Candidiasis; Concanavalin A; Cytomegalovirus Infections; Fluorescent Antibo | 1973 |
An evaluation of the mechanism of action of pentamidine isethionate.
Topics: Amides; Amino Acids; Animals; Antiprotozoal Agents; Ascitic Fluid; Carbon Isotopes; DNA; In Vitro Te | 1970 |